Table 2 Experiment 2 (antitumor effect)
From: Using water-soluble C60 fullerenes in anticancer therapy
Number of days after tumor transplantation | Group 0 (control) | Group 1 (injection of C60FAS before tumor transplantation) | Tumor growth inhibition*, | Group 2 (injection of C60FAS after tumor transplantation) | Tumor growth inhibition*, |
|---|---|---|---|---|---|
13 | n = 7 | n = 7 | 15.0 | n = 7 | 4.0 |
16 | n = 7 | n = 7 | 27.2 | n = 7 | 25.1 |
21 | n = 7 | n = 7 | 25.0 | n = 7 | 5.4 |
23 | n = 4 | n = 7 | 23.3 | n = 7 | 17.0 |
27 | n = 2 | n = 6 | 35.0 | n = 6 | 5.0 |
29 | n = 2 | n = 3 | n = 6 | ||
30 | n = 0 | n = 2 | n = 6 | ||
33 | n = 2 | n = 4 | |||
34 | n = 2 | n = 2 | |||
37 | n = 2 | n = 0 | |||
54 | n = 0 |
, %
, %
*
*- Start of C60FAS injection before the tumor transplantation—07 February 2011 (group 1; protective effect). Start of tumor transplantation—17 February 2011. Start of C60FAS injection after the tumor transplantation—19 February 2011 (group 2; inhibitive effect). Initial number of animals in experimental groups was n = 7. Survival of animals (
, %) and increasing of animal life (
, %) are given in parentheses - *p < 0.05, the differences are statistically valid compared with the control
, %) and increasing of animal life (
, %) are given in parentheses